lumasiran

Showing 1 posts of 1 posts found.

alnylam_credit_-_business_wire

Alnylam’s lumasiran hits main Phase 3 goal in rare renal disease primary hyperoxaluria type 1

June 9, 2020
Manufacturing and Production, Research and Development Alnylam, lumasiran, pharma, rare disease

Alnylam has presented promising new Phase 3 data at the European Renal Association-European Dialysis and Transplant Association International Congress for …

The Gateway to Local Adoption Series

Latest content